Business
Halberd Corporation's VITA-SHIELD-MAX(TM) Immunity Support Product Shipped
Halberd Corporation's VITA-SHIELD-MAX(TM) Immunity Support Product Shipped.
About this update from Halberd Corp.
[{"type":"text","content":"Jackson Center, Pennsylvania--(Newsfile Corp. - August 9, 2021) - Halberd Corporation (OTC Pink: HALB) reports Vita-Shield-MaxTM, has been shipped! With COVID-19 cases back on the rise fueled by the Delta Variant, this \"Immunity Support Nutraceutical Product\" is arriving at the right time.William A. Hartman, Halberd's Chairman, President & CEO, stated, \"We will shortly begin selling Vita-Shield-MaxTM and will be releasing details on purchasing our product in the near future, once we have the product in inventory.\"Halberd Corporation released a 120-page compilation of medical articles in support of its Vita-Shield-MaxTM Nutraceutical product earlier.To get the latest news on Halberd's exciting developments, including our ongoing disease eradication accomplishments, subscribe by submitting this form.(https://halberdcorporation.com/contact-us/)For more information please contact:William A. [email protected];[email protected]://www.halberdcorporation.comTwitter:@HalberdCAbout Halberd Corporation.Halberd Corporation (OTC Pink: HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements. It holds the exclusive worldwide rights to several patent- and PCT-pending extracorporeal treatments for COVID-19 and other medical maladies: Halberd also holds the exclusive rights to the underlying granted U.S. Patent 9,216,386 and U.S. Patent 8,758,287.Safe Harbor NoticeCertain statements contained herein are \"forward-looking statements\" (as defined in the Private Securities Litigation Reform Act of 1995). The Companies caution that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives -On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the...